Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2003; 8: 67
At the end of September 2001, the Dutch Inspectorate for Health Protection and Veterinary Public Health and the National Poisons Control Centre (NPCC) were informed about adverse health effects after consumption of a herbal tea. During consultations, it was suggested that Japanese star anise (Illicium anisatum L.), which is known to contain a neurotoxin, might have been inadvertently mixed into the herbal tea. In view of the severity of the adverse health effects and the clear association with consumption of a specific herbal tea, the supplier was urgently advised to withdraw the suspected herbal tea from the market. A total of 63 persons reported symptoms of general malaise, nausea and vomiting 2–4 h after consumption of the herbal tea. Of these, 22 required hospitalisation, 16 of them due to generalised tonic–clonic seizures. Medical investigations revealed no underlying pathology and after supportive treatment, the patients were discharged in good health. Morphological and organoleptic investigations of the suspected herbal tea indicated that this possibly contained Japanese star anise. Nuclear magnetic resonance analysis of the herbal tea confirmed the presence of the neurotoxin anisatin, a non-competitive γ-aminobutyric acid (GABA)-antagonist which can cause hyperactivity of the central nervous system and tonic–clonic seizures.